A new study indicates the blood thinner Savaysa increases the risk of gastrointestinal bleeding for TAVR patients with atrial fibrillation when compared to warfarin.
The blood thinner Savaysa was linked to an increased risk of major bleeding when compared to some forms of heparin, according to the findings of a new study.
The ISMP reports that Xarelto and similar blood thinners were linked to more than 3,000 reports of patient deaths submitted to the FDA in 2016, mostly due to bleeding injuries.
A proposed reversal agent for the blood thinners Xarelto and Eliquis suffered a setback this week when the FDA rejected its approval, asking questions about manufacturing and its potential use…
A new blood thinner approved by the FDA carries a black box warning that it may be less effective in patients with normal kidney functions.
Clinical trials have shown some success in the development for a Xarelto reversal agent, as manufacturers race to develop antidotes for blood thinners linked to deadly and uncontrollable bleeding problems.
